<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02592694</url>
  </required_header>
  <id_info>
    <org_study_id>Cocktail I</org_study_id>
    <nct_id>NCT02592694</nct_id>
  </id_info>
  <brief_title>Intracoronary Cocktail Injection Combined With Thrombus Aspiration in STEMI Patients Treated With Primary Angioplasty</brief_title>
  <official_title>Intracoronary Cocktail Injection Combined With Thrombus Aspiration in ST-elevation Myocardial Infarction Patients Treated With Primary Angioplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double blind, placebo controlled study of intracoronary cocktail
      injection combined with thrombus aspiration versus thrombus aspiration alone in ST-elevation
      myocardial infarction patients treated with primary angioplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized, double blind, placebo controlled study of intracoronary cocktail
      injection combined with thrombus aspiration versus thrombus aspiration alone in ST-elevation
      myocardial infarction patients treated with primary angioplasty. Patients with STEMI will be
      randomized into the cocktail group or the control group. Patients in the cocktail group will
      receive cocktail injection combined with thrombus aspiration. Patients in the control group
      will receive thrombus aspiration alone. The primary outcome of the cocktail I study is the
      composite of death, myocardial infarction or class IV heart failure within 1 year. The
      secondary outcome of the cocktail I study include slow reflow/no reflow during PCI, left
      ventricular function, quality of life, stroke or life-threatening bleeding within 1 year.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2015</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Death, Mayocardial infarction, NYHA Ⅳ heart failure</measure>
    <time_frame>1 year</time_frame>
    <description>number of participants with death, mayocardial infarction or NYHA Ⅳ heart failure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Slow reflow/no reflow</measure>
    <time_frame>intraoperative</time_frame>
    <description>number of participants with slow reflow/no reflow during PCI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left ventricular function</measure>
    <time_frame>1 year</time_frame>
    <description>left ventricular ejection fraction evaluated by ultrasound and MRI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seattle Angina Questionnaire scores</measure>
    <time_frame>1 year</time_frame>
    <description>Seattle Angina Questionnaire scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Canadian Cardiovascular Society (CCS) Functional Angina classification</measure>
    <time_frame>1 year</time_frame>
    <description>Canadian Cardiovascular Society (CCS) Functional Angina classification</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-minute walk distance (6MWD)</measure>
    <time_frame>1 year</time_frame>
    <description>6-minute walk distance (6MWD)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>1 year</time_frame>
    <description>number of participants with stroke</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>ST-elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Cocktail with thrombus aspiration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intracoronary cocktail (tirofiban, bivalirudin, tenecteplase) injection combined with thrombus aspiration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thrombus aspiration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thrombus aspiration alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cocktail</intervention_name>
    <description>Cocktail (tirofiban, bivalirudin, tenecteplase) will be given in addition to thrombus aspiration</description>
    <arm_group_label>Cocktail with thrombus aspiration</arm_group_label>
    <other_name>tirofiban, bivalirudin, tenecteplase</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>thrombus aspiration</intervention_name>
    <description>manual thrombus aspiration</description>
    <arm_group_label>Cocktail with thrombus aspiration</arm_group_label>
    <arm_group_label>Thrombus aspiration</arm_group_label>
    <other_name>manual thrombus aspiration</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-80 years of age adult patients with STEMI Referred for primary PCI within 5d of
             symptom onset

        Exclusion Criteria:

          -  Patients who had undergone previous coronary artery bypass surgery or PCI or had
             received fibrinolytic therapy History of stroke Active bleeding Severe hepatic or
             renal dysfunction Cardiogenic shock Contraindications for primary PCI or DAPT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dongdong Sun, M.D.,Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fourth Military Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dongdong Sun, M.D.,Ph.D.</last_name>
    <phone>86 29 84775183</phone>
    <email>wintersun3@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xijing hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dongdong Sun, M.D.,Ph.D</last_name>
      <phone>86 18691569930</phone>
      <email>wintersun3@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2015</study_first_submitted>
  <study_first_submitted_qc>October 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 30, 2015</study_first_posted>
  <last_update_submitted>October 28, 2015</last_update_submitted>
  <last_update_submitted_qc>October 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xijing Hospital</investigator_affiliation>
    <investigator_full_name>sunddong</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bivalirudin</mesh_term>
    <mesh_term>Tirofiban</mesh_term>
    <mesh_term>Tenecteplase</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

